Dr Reddy’s and Shanghai Henlius sign agreement for HLX15
A recombinant anti-CD38 fully human monoclonal antibody injection, HLX15 comes in both intravenous and subcutaneous ...
Daily2d
Dr Reddy's Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe
Hyderabad: Dr Reddy's Laboratories SA, a wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd. has announced that it has ...
Dr. Reddy’s in licenses biosimilar for J&J’s multiple myeloma therapy
Dr. Reddy's (RDY) partners with Shanghai Henlius Biotech to develop and market biosimilar versions of J&J's (JNJ) multiple ...
Dr. Reddy’s, Shanghai Henlius Biotech ink $131.6 million cancer drug deal
Dr. Reddy’s to develop and commercialize biosimilar candidate for Johnson & Johnson’s Darzalex drugs with Shanghai Henlius Biotech.
Dr Reddy's in pact with Shanghai Henlius Biotech for exclusive US, Europe rights for daratumumab biosimilar
HYDERABAD: Dr Reddy’s Laboratories SA, the wholly-owned Swiss subsidiary of Hyderabad-based pharma biggie Dr Reddy’s Laboratories Ltd, has entered into a licence agreement with Shanghai Henlius ...
Le Lézard3d
Terrestar Solutions, a leading Canadian provider of mobile satellite communications, closes a major round of funding
Terrestar Solutions, Canada's only mobile satellite operator, recently closed on a financing deal with TD Bank Group. Headquartered in Montreal, Terrestar has exclusive rights to the Canadian capacity ...
Le Lézard3d
EnsembleIQ's Product of the Year Canada Announces 2025 Award Winners
EnsembleIQ's Product of the Year Canada, the largest consumer-voted, globally recognized award for product innovation, today announces the winners of the 2025 Product of the Year Awards. With winners ...
Dr Reddy’s arm ties up with Shanghai Henlius Biotech
New Delhi: Dr Reddy’s Laboratories on Thursday said its subsidiary has inked a licence agreement with Shanghai Henlius ...
Pharmabiz3d
Dr Reddy’s inks pact with Henlius to commercialize HLX1, a biosimilar candidate in US & Europe
Dr Reddy’s inks pact with Henlius to commercialize HLX1, a biosimilar candidate in US & Europe: Our Bureau, Bengaluru Thursday, February 6, 2025, 17:20 Hrs [IST] Dr Reddy’s La ...
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
Shanghai Henlius Biotech, Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd., (BSE: ...
devdiscourse3d
Dr Reddy's and Shanghai Henlius Join Forces for Cancer Breakthrough
Dr Reddy’s Laboratories has signed a license deal with Shanghai Henlius Biotech to develop and market HLX15, an investigational cancer drug. Henlius will handle development and manufacturing, ...